Table 3 Seroprevalence of anti-T. gondii IgG antibodies in schizophrenic patients and controls according to age groups.
From: Seroepidemiology of Toxoplasma gondiiinfection in psychiatric inpatients in a northern Mexican city
Schizophrenic patients | Controls | ||||||
|---|---|---|---|---|---|---|---|
T. gondii infection | T. gondii infection | ||||||
Age groups | No. Tested | No. | % | No. tested | No. | % | P value |
25–34 | 5 | 0 | 0 | 48 | 3 | 6.3 | 0.73 |
35–44 | 6 | 1 | 16.7 | 32 | 4 | 12.5 | 0.59 |
45–54 | 17 | 7 | 41.2 | 9 | 1 | 11.1 | 0.12 |
55–64 | 5 | 1 | 20 | 8 | 1 | 12.5 | 0.64 |
65–74 | 2 | 0 | 0 | 31 | 5 | 16.1 | 0.71 |
75–84 | 3 | 1 | 33.3 | 12 | 0 | 0 | 0.2 |
All | 38 | 10 | 26.3 | 140 | 14 | 10 | 0.01 |